Recent Finacing
Recent Raise
Kronos Bio is a biopharma using a Small Molecule Microarray and targeted protein degradation to discover modulators and degraders of dysregulated transcription factors, advancing MYC, AR, SYK, CDK9 programs.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Kronos Bio.
